Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Outcomes of ibrutinib-treated patients with chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) with high-risk prognostic factors in an integrated analysis of 3 randomized phase 3 studies Kipps, T. J., Mahler, M., Fraser, G., Coutre, S., Brown, J., Barrientos, J., Barr, P., Byrd, J. C., O'Brien, S., Dilhuydy, M., Jaeger, U., Moreno, C., Cramer, P., Stilgenbauer, S., Chanan-Khan, A., Salman, M., Cheng, M., Londhe, A., Ninomoto, J., Howes, A., James, D., Hallek, M., Hillmen, P. TAYLOR & FRANCIS LTD. 2017: 10–12
View details for Web of Science ID 000423431100010